Fasting activation of AgRP neurons requires NMDA receptors and involves spinogenesis and increased excitatory tone

Neuron. 2012 Feb 9;73(3):511-22. doi: 10.1016/j.neuron.2011.11.027.

Abstract

AgRP neuron activity drives feeding and weight gain whereas that of nearby POMC neurons does the opposite. However, the role of excitatory glutamatergic input in controlling these neurons is unknown. To address this question, we generated mice lacking NMDA receptors (NMDARs) on either AgRP or POMC neurons. Deletion of NMDARs from AgRP neurons markedly reduced weight, body fat and food intake whereas deletion from POMC neurons had no effect. Activation of AgRP neurons by fasting, as assessed by c-Fos, Agrp and Npy mRNA expression, AMPA receptor-mediated EPSCs, depolarization and firing rates, required NMDARs. Furthermore, AgRP but not POMC neurons have dendritic spines and increased glutamatergic input onto AgRP neurons caused by fasting was paralleled by an increase in spines, suggesting fasting induced synaptogenesis and spinogenesis. Thus glutamatergic synaptic transmission and its modulation by NMDARs play key roles in controlling AgRP neurons and determining the cellular and behavioral response to fasting.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • 6-Cyano-7-nitroquinoxaline-2,3-dione / pharmacology
  • Age Factors
  • Agouti-Related Protein / deficiency
  • Agouti-Related Protein / metabolism*
  • Animals
  • Body Composition / drug effects
  • Body Composition / genetics
  • Brain / cytology
  • Carrier Proteins / genetics
  • Dendritic Spines / drug effects
  • Dendritic Spines / physiology*
  • Eating / drug effects
  • Eating / physiology
  • Energy Metabolism / drug effects
  • Energy Metabolism / genetics
  • Excitatory Amino Acid Antagonists / pharmacology
  • Excitatory Postsynaptic Potentials / drug effects
  • Excitatory Postsynaptic Potentials / genetics
  • Fasting*
  • Female
  • GABA Antagonists / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Green Fluorescent Proteins / genetics
  • In Vitro Techniques
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / genetics
  • Mice
  • Mice, Transgenic
  • Nerve Tissue Proteins / deficiency
  • Nerve Tissue Proteins / genetics
  • Neurons / cytology*
  • Neurons / drug effects
  • Neuropeptide Y / genetics
  • Patch-Clamp Techniques
  • Picrotoxin / pharmacology
  • Pro-Opiomelanocortin / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate / deficiency
  • Time Factors

Substances

  • Agouti-Related Protein
  • Agrp protein, mouse
  • Carrier Proteins
  • Excitatory Amino Acid Antagonists
  • GABA Antagonists
  • Gprin1 protein, mouse
  • Nerve Tissue Proteins
  • Neuropeptide Y
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Receptors, N-Methyl-D-Aspartate
  • Picrotoxin
  • Green Fluorescent Proteins
  • Pro-Opiomelanocortin
  • 6-Cyano-7-nitroquinoxaline-2,3-dione
  • 2-Amino-5-phosphonovalerate